Bill > S08544

This bill amends New York state law to protect the prescribing, dispensing, and receipt of mifepristone (a medication used for medication abortion) from being considered a criminal act or being deemed misbranded under certain circumstances. Specifically, the bill ensures that these medications cannot be considered a criminal diversion act or adulterated/misbranded solely if they are no longer FDA-approved or do not bear their original label, provided two key conditions are met: (1) the medication's original labeling was true and accurate at the time of manufacture, and (2) the drug is being recommended for its prescribed purpose according to current World Health Organization (WHO) guidelines. This legislation appears designed to protect healthcare providers and patients from potential legal complications arising from changes in medication approval status or labeling, particularly in the context of abortion medications. The bill includes a severability clause, meaning that if any part of the law is found invalid, the rest of the law can remain in effect, and it is set to take effect immediately upon passage.

Housing and Urban Affairs

https://www.nysenate.gov/legislation/bills/2025/S8544